Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the global intraoperative imaging market. In addition, complete analysis of changes on the global intraoperative imaging market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 pandemic has had a significant impact on the intraoperative imaging market. On the other side, with relaxation of government imposed lockdown protocols, the market is expected to recover from the economic crisis and is expected to have new growth opportunities over the forecast period.
The growth in the market can be attributed to the increased adoption of minimally invasive surgery coupled with technological advances. Furthermore, the growing prevalence of chronic diseases and the increase in the geriatric population are important factors contributing to the growth of the market. The global geriatric population has grown enormously, putting it at risk for several conditions. According to the United Nations, the world population aged 60 and over was 962 million in 2017, doubling to over 2.1 billion by 2050.
Emerging markets offer significant growth opportunities for major players in the intraoperative imaging market. Although cost is an issue in these developing countries, their large population bases – particularly in India and China – indicate a sustainable market for intraoperative imaging devices.
Moreover, regulatory policies in Asia-Pacific are more adaptable and more business-friendly than in Western countries. Increasing competition in mature markets is expected to force intraoperative imaging systems manufacturers to focus on emerging markets. This is expected to create new growth opportunities for the market in the upcoming years.
Intraoperative imaging systems are expensive and require significant capital investment for facilities, which increases the cost of the procedure for patients. This affects the rate of adoption of new systems, especially in emerging markets; As a result, most healthcare facilities in these countries cannot afford such systems. Healthcare facilities that purchase such expensive systems often rely on third-party payers (such as Medicare, Medicaid, or private health insurance companies) to reimburse costs associated with screening and treatment procedures performed with these systems. As a result, factors such as continued reductions in reimbursements for intraoperative imaging exams and the rising cost of intraoperative imaging systems are preventing small and medium-sized healthcare facilities from investing in imaging modalities. These factors are expected to restrain the market growth over the forecast period.
The Covid-19 pandemic hampered the growth of market to major extent which has created a major challenges for the market growth. Also, high cost of intraoperative imaging systems and an increase in demand for refurbished imaging systems along with lack of skilled work force are the factors which is expected to be a major challenge for the market growth over the forecast the period.
The report provides in-depth analysis of global intraoperative imaging market, market size, and compound annual growth rate (CAGR) for the forecast period of 2022-2028, considering 2021 as the base year. With increasing demand for various intraoperative imaging devices in various applications has led the increasing demand for market and is expected to witness the growth at a specific CAGR from 2021-2028.
The global intraoperative imaging market comprises of different market segment like product, application, end users and geography.
By product, the intraoperative imaging market includes the key segments of
The C-arm system segment is expected to dominate the market over the forecast period. This is due to its flexibility to move around the patient, allowing it to achieve the best angle for a high quality image while keeping the patient comfortable. Moreover, technological developments are expected to drive the segment forward over the forecast period.
The Intraoperative Imaging market has major applications in
The neurosurgery segment is expected to maintain its dominance over the estimated time period. Due to the growing burden of neurological diseases including epilepsy, stroke, Parkinson's disease, migraines, brain tumours, multiple sclerosis, Alzheimer's disease and other dementias. Intraoperative imaging results are life-changing because they allow neurosurgeons to operate with greater precision and accuracy, minimize the need for additional procedures, and prevent patients from acquiring infection during transfers in and out of operation rooms. The oncology segment is expected to grow at a high rate over the forecast period.
The Intraoperative Imaging market has major end users like
The hospitals and clinics segment is expected to maintain its dominance over the estimated time period. Hospitals regularly perform a wide variety of surgical procedures, and most of these surgeries are performed in hospital settings. The growth in this segment is mainly attributed to the growing number of minimally invasive and electrosurgical surgeries in hospitals and the adoption of robotic surgery. The acceptance of intraoperative imaging tools is greater in hospitals, due to their greater purchasing power and the greater number of operations performed. The growing incidence of road accidents, fall injuries and sports injuries has led to an increasing number of orthopaedic surgeries in hospitals; adding to the volume of the procedure, the increasing incidence of conditions requiring surgical treatment supports the use of intraoperative imaging equipment.
The global Intraoperative Imaging market is studied for the following region
North America region is expected to lead the market growth over the forecast period. The region is anticipated to witness increasing demand for intraoperative imaging devices owing to presence to well established market players. A significant number of market players are present in the region and their ongoing efforts to develop new products, invest in acquisitions and R&D to support simple operations and ensure the availability of authentic medical grade imaging systems are expected to drive market growth.
The competitive landscape analysis of Intraoperative Imaging market is majorly focused on expanding the global growth of Intraoperative Imaging with new product innovation, business expansion, increasing presence of range of manufacturers operating in intraoperative imaging devices has led the growing demand for the market. Besides, the market offers range of products in different application to fulfil the required demand of consumer which is further contributing healthy growth in the market.
The key players studied in market are
September 2021: GE Healthcare had agreed to acquire BK Medical, specialized in advanced surgical visualization. With this agreement, BK Medical's active imaging platform is expected to reach new customers and markets around the world.
April 2021: Activ Surgical, had announced the U.S. Food and Drug Administration (FDA) clearance of the company's ActivSight Intraoperative Imaging Module for enhanced surgical visualization.
| Market
Sizing for Year: | 2021-2028 |
| Base
Year: | 2021 |
| Forecast
Period: | 2022-2028 |
| Value: | USD million |
| Market
Segment studied: | Product Application End Users |
| Market
Players and its Competitors: | Siemens
Healthineers AG (Germany) GE
Healthcare (US) Medtronic
(Ireland) Ziehm
Imaging GmbH (Germany) Koninklijke
Philips N.V. (Netherlands) Brainlab
AG (Germany) Canon
Healthcare (Japan) Carl Zeiss
Meditec AG (Germany) Fujifilm
Holdings (Japan) IMRIS
(Canada) Hitachi,
Ltd. (Japan) Shenzhen
Anke High-tech Co. (China) Shimadzu
Corporation (Japan) NeuroLogica
(US) Carestream
Health (US) Analogic
Corporation (US) |
